What is the debt of MEI Pharma this year?
MEI Pharma has a debt level of -16.9 USD this year.
MEI Pharma Debt 2024
MEI Pharma Debt
-16.9 USD
Ticker
MEIP
ISIN
US55279B2025
WKN
A1KATX
In 2024, MEI Pharma's total debt was -16.9 USD, a 7.64% change from the -15.7 USD total debt recorded in the previous year.
MEI Pharma Aktienanalyse
What does MEI Pharma do?
MEI Pharma Inc. is a pharmaceutical company focused on the development and commercialization of cancer-related therapeutics. It was founded in 2000 and is headquartered in San Diego, California. MEI Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding MEI Pharma's Debt Structure
MEI Pharma's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing MEI Pharma's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to MEI Pharma’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in MEI Pharma’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about MEI Pharma stock
What was the debt of MEI Pharma compared to the previous year?
The debt of MEI Pharma has increased by 7.64% compared to the previous year increased.
What are the consequences of high debt for investors in MEI Pharma?
High debt can pose a risk for investors of MEI Pharma, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of MEI Pharma?
Low debt means that MEI Pharma has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from MEI Pharma affect the company?
An increase in debt of MEI Pharma can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of MEI Pharma affect the company?
A reduction in debt of MEI Pharma can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of MEI Pharma?
Some factors that can influence the debt of MEI Pharma include investments, acquisitions, operating costs, and revenue development.
Why are the debts of MEI Pharma so important for investors?
The debts of MEI Pharma are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can MEI Pharma take to change the debt?
To change the debt, MEI Pharma can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does MEI Pharma pay?
Over the past 12 months, MEI Pharma paid a dividend of 1.75 USD . This corresponds to a dividend yield of about 58.72 %. For the coming 12 months, MEI Pharma is expected to pay a dividend of 1.75 USD.
What is the dividend yield of MEI Pharma?
The current dividend yield of MEI Pharma is 58.72 %.
When does MEI Pharma pay dividends?
MEI Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MEI Pharma?
MEI Pharma paid dividends every year for the past 0 years.
What is the dividend of MEI Pharma?
For the upcoming 12 months, dividends amounting to 1.75 USD are expected. This corresponds to a dividend yield of 58.72 %.
In which sector is MEI Pharma located?
MEI Pharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von MEI Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MEI Pharma from 12/6/2023 amounting to 1.75 USD, you needed to have the stock in your portfolio before the ex-date on 11/16/2023.
When did MEI Pharma pay the last dividend?
The last dividend was paid out on 12/6/2023.
What was the dividend of MEI Pharma in the year 2023?
In the year 2023, MEI Pharma distributed 0 USD as dividends.
In which currency does MEI Pharma pay out the dividend?
The dividends of MEI Pharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The MEI Pharma stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von MEI Pharma
Our stock analysis for MEI Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MEI Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
